BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:IDE034 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of IDE034\, from ClinicalTrials.gov estimate
 s.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07503808-2534@assetmemo.bio
DTSTAMP:20261121T005209Z
DTSTART;VALUE=DATE:20270730
DTEND;VALUE=DATE:20270731
SUMMARY:IDE034: Phase 1 readout est. (NCT07503808)
DESCRIPTION:IDE034\, phase 1\, Non-Small Cell Lung Cancer.\nStudy: A Study 
 of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tum
 ors Types\nEstimated primary completion: 30 July 2027. This is a ClinicalT
 rials.gov estimate\, not a confirmed readout date\, and it can move.\nDrug
  page: https://assetmemo.bio/drug/ide034#upcoming-events\nRegistry record:
  https://clinicaltrials.gov/study/NCT07503808
URL:https://assetmemo.bio/drug/ide034#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
